tradingkey.logo
tradingkey.logo
Pesquisar

Elevance Health Inc

ELV
Adicionar à lista de desejos
408.235USD
-9.655-2.31%
Fechamento 07/06, 16:00ETCotações atrasadas em 15 min
90.11BValor de mercado
17.25P/L TTM

Mais detalhes de Elevance Health Inc Empresa

Elevance Health, Inc. is a health company. It operates as a health insurer in the United States. The Company operates through four segments: Health Benefits, CarelonRx, Carelon Services and Corporate & Other. The Health Benefits segment offers a comprehensive suite of health plans and services to its Individual, Employer Group risk-based, Employer Group fee-based, BlueCard, Medicare, Medicaid and Federal Employee Program (FEP) members. The Health Benefits segment also offers health products on a full-risk basis. The CarelonRx segment includes its pharmacy services business. CarelonRx markets and offers pharmacy services to its affiliated health plan customers, as well as to external customers outside of the health plans. The Carelon Services segment integrates physical, behavioral, pharmacy, and social services by offering an array of healthcare-related services and capabilities to internal and external customers through its Carelon Health and Carelon Insights businesses.

Informações de Elevance Health Inc

Código da empresaELV
Nome da EmpresaElevance Health Inc
Data de listagemOct 30, 2001
CEOBoudreaux (Gail K)
Número de funcionários103158
Tipo de títulosOrdinary Share
Fim do ano fiscalOct 30
Endereço220 Virginia Avenue
CidadeINDIANAPOLIS
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal46204
Telefone18003311476
Sitehttps://www.elevancehealth.com/
Código da empresaELV
Data de listagemOct 30, 2001
CEOBoudreaux (Gail K)

Executivos da empresa Elevance Health Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Ramiro G. Peru
Mr. Ramiro G. Peru
Independent Chairman of the Board
Independent Chairman of the Board
9.91K
+5.68%
Mr. Antonio F. Neri
Mr. Antonio F. Neri
Independent Director
Independent Director
5.49K
+10.26%
Dr. Bahija Jallal, Ph.D.
Dr. Bahija Jallal, Ph.D.
Independent Director
Independent Director
5.35K
+10.52%
Mr. Ronald W. Penczek
Mr. Ronald W. Penczek
Chief Accounting Officer, Controller
Chief Accounting Officer, Controller
3.55K
-10.40%
Ms. Deanna D. Strable-Soethout
Ms. Deanna D. Strable-Soethout
Independent Director
Independent Director
2.21K
+25.49%
Mr. Robert L. Dixon, Jr.
Mr. Robert L. Dixon, Jr.
Independent Director
Independent Director
--
--
Mr. Lewis (Lew) Hay, III
Mr. Lewis (Lew) Hay, III
Independent Director
Independent Director
--
--
Mr. Peter D. (Pete) Haytaian
Mr. Peter D. (Pete) Haytaian
Executive Vice President and President, Carelon and CarelonRx
Executive Vice President and President, Carelon and CarelonRx
--
--
Mr. R. Kerry Clark
Mr. R. Kerry Clark
Independent Director
Independent Director
--
--
Ms. Gail K. Boudreaux
Ms. Gail K. Boudreaux
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Ramiro G. Peru
Mr. Ramiro G. Peru
Independent Chairman of the Board
Independent Chairman of the Board
9.91K
+5.68%
Mr. Antonio F. Neri
Mr. Antonio F. Neri
Independent Director
Independent Director
5.49K
+10.26%
Dr. Bahija Jallal, Ph.D.
Dr. Bahija Jallal, Ph.D.
Independent Director
Independent Director
5.35K
+10.52%
Mr. Ronald W. Penczek
Mr. Ronald W. Penczek
Chief Accounting Officer, Controller
Chief Accounting Officer, Controller
3.55K
-10.40%
Ms. Deanna D. Strable-Soethout
Ms. Deanna D. Strable-Soethout
Independent Director
Independent Director
2.21K
+25.49%
Mr. Robert L. Dixon, Jr.
Mr. Robert L. Dixon, Jr.
Independent Director
Independent Director
--
--

Perguntas frequentes

Quem são os cinco principais acionistas de Elevance Health Inc?

Os cinco principais acionistas de Elevance Health Inc são: Mr. Ramiro G. Peru

Quantas instituições possuem ações da Elevance Health Inc (ELV)?

Em 2026Q1, 3164 instituições possuíam ações da Elevance Health Inc, com valor de mercado aproximado de 206.68M, representando 95.17% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em -8943966.00.